Ads
related to: what is multiple myeloma- About Multiple Myeloma
Learn More About Treatments At
First Relapse For Your Patients.
- Efficacy Information
Review Clinical Data, Results,
Study Overviews, And More.
- HCP FAQs
Discover Answers To Commonly Asked
Questions At The Official HCP Site.
- Access & Reimbursement
Find Support, Tools, And Resources
For HCPs, Caregivers And Patients.
- Connect With A Rep
Contact A Field Representative For
Questions Or To Schedule A Visit.
- Safety Information
View Safety Profiles For
A Combination Treatment.
- About Multiple Myeloma
Search results
GSK blood cancer drug nearly halves risk of death in late-stage trial
Reuters via AOL· 6 days agoGSK's multiple myeloma drug Blenrep nearly halved the risk of disease progression or death compared...
AbbVie treats first subject in Phase III multiple myeloma drug trial
Clinical Trials Arena via Yahoo Finance· 2 days agoAbbVie has treated the first subject in the Phase III CERVINO clinical trial of its investigational...
AbbVie makes oncology progress with two drug trials
Crain s Chicago Business· 2 days agoMultiple myeloma, the second-most common blood cancer, is characterized by abnormal proliferation of plasma cells, which can cause end-organ damage, AbbVie ...
CARVYKTI® (ciltacabtagene autoleucel) significantly improved progression-free survival and deepened...
Valley City Times Record· 4 days agoJohnson & Johnson announced today results from a subgroup analysis of the Phase 3 CARTITUDE-4 study. Data from the CARTITUDE-4 study supported the recent U.S. FDA approval of CARVYKTI®, the ...
Become part of a movement to accelerate a cure for multiple myeloma!
Digital Journal· 3 days agoPRESS RELEASE Published June 5, 2024 24-7 Press Release Multiple Myeloma Research Foundation® Walk/Run DETROIT, MI, June 05, 2024 /24-7PressRelease/ -- ...
DARZALEX® (daratumumab)-based regimens significantly improve clinical outcomes in both...
Valley City Times Record· 4 days agoThe rates of deep and sustained MRD negativity were associated with improved progression-free...
Adding Isatuximab to Standard Backbone Improves Outcomes in Multiple Myeloma
MedPage Today· 4 days agoTwo trials show positive outcomes
TECVAYLI® (teclistamab-cqyv) shows sustained deep and durable responses in patients with relapsed or...
Valley City Times Record· 5 days ago"With the longest follow-up of any bispecific antibody, teclistamab demonstrates continued deep and durable responses observed in patients with relapsed or refractory multiple
GSK's Blenrep Combo Therapy Cuts Risk Of Disease Progression Or Death By Around 50% In Pretreated ...
Benzinga· 4 days agoThe data were presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting. On...
AbbVie (ABBV) Starts Late-Stage Study on Multiple Myeloma Drug
Zacks via Yahoo Finance· 2 days agoThe late-stage study will evaluate AbbVie's (ABBV) experimental antibody to treat patients with...
Ad
related to: what is multiple myeloma